BCL2L1 and neuroblastoma: Transgenic expression of MCL1, however, indirectly slows down BECN1 activation by sequestering NOXA away from BCLXL, as NOXA binds MCL1 with higher affinity than BCLXL in neuroblastoma cells [44].